Engineered foamy virus (FV) vectors have been lauded for their superior safety profiles and stable integration patterns compared to their gammaretroviral counterparts. The drawback has been the belief that FV incorporation is cell cycledependent, thereby limiting its utility in post-mitotic tissues such as the central nervous system. In this brief communication, we challenged this theory by examining FV in vivo. We injected equal titers of FV and lentivirus (LV) into the adult rat brain and found that at 1 week, FV transduced a significantly greater volume of bromodeoxyuridine (BrdU)-negative brain parenchyma than did LV. By 8 weeks, however, the volume of transduced tissue was greatly reduced-comparable to LVand restricted to BrdU+. Taken together, these data implicate a role for FV in short-term gene delivery strategies to the CNS.
Gene therapy is a promising therapeutic technique for disorders of the central nervous system (CNS). However, effectiveness in clinical trials has been limited due to physiologic barriers unique to this organ system as well as the post-mitotic state of many of the cellular targets in the brain and spinal cord. Currently, the HIV-derived lentivirus (LV) and adeno-associated virus represent the most widely used viral transfer vectors for CNS gene delivery. The former is limited by relatively low titers, gene capacity and safety concerns; the latter is limited by short-term expression of transgenes. A recently described potential alternative to these vectors is foamy virus (FV). 1 FV constitute a subfamily (Spumavirinae) of Retroviridae that are endemic in some mammalian species including chimpanzee and cats, but not in human populations. 2, 3 To date, exposure and subsequent infection of humans with FV have not been associated with any pathology, and human-to-human transmission has yet to be shown. Moreover, long-term studies of infected animal care workers have failed to show negative consequences. 4 In fact, FV does not appear to be pathogenic even in its natural mammalian hosts and infection is not associated with an increased risk of developing malignancies. 5 In addition to its safety benefits, FV possesses several novel properties and characteristics essential for effective gene delivery. The FV life cycle is unique, in that singlestranded viral RNA is converted into double-stranded DNA (DS DNA) within virion-producing cells 6 unlike LV and Moloney leukemia virus (MLV) where reverse transcription to DS DNA occurs in target cells. This is significant in that it affords FV improved stability relative to LV and MLV, as it is able to transcribe DNA independent of target cell nucleotide pools and can then use DNA as the functional genome. This aspect also allows the FV genome to be sustained as a preintegration complex that can enter the nucleus in the absence of mitosis. Once cell division commences, it can integrate into the genome and the transgene can be expressed. 7 In general, the ability of a virus to integrate into genomic DNA offers the possibility of long-term transgene expression, but with the associated risk of malignant transformation resulting from insertional mutagenesis and oncogene activation. The potential to produce cell transformation by this mechanism was unfortunately realized in a gene therapy clinical trial in which several patients developed leukemia after retroviral integration near the LMO2 protooncogene. 8 This negative potential is highly dependent on the location of viral integration into the host genome. Specifically, it has been determined that MLV preferentially integrates into active promoter regions and LV prefers integration into actively transcribed DNA. 9, 10 However, FV has a unique integration pattern that favors non-transcribed areas of chromosomal DNA, which increases its appeal as a safe gene transfer vehicle.
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In addition to its attractive integration pattern and safety gains, FV vectors have shown a broad host range, large packaging capacity and the ability to concentrate stable virions by ultracentrifugation. 1 For example, the FV system has been shown to effectively transduce human fibroblasts, 11 human hematopoeitic stem cells 12 and rat hippocampal neurons in vitro 13 as well as cells derived from other various mammalian species. The FV system also appears to transduce multiple different cell types with equal efficiency, suggesting that a receptor mediating infection may be broadly expressed in many tissue types. 14, 15 Although FV appears to have many advantages for gene transfer, controversy still exists regarding the cellcycle dependence of FV genomic integration, which might undermine its potential as an effective vehicle for delivery to post-mitotic tissues such as the CNS. Trobridge and Russell 16 reported that FV-mediated transgene expression is dependent on cell mitosis but not on DNA synthesis. They also suggested that FV vectors may only work in quiescent stem cells that later divide and thereby permit integration. By implication, this would suggest that FV vectors may not be suited for the CNS in which the majority of the cells are post-mitotic. In this study, we produced replication-incompetent LV and FV and applied both, at equal titers, to cells in vitro and then directly in the CNS of adult rats to compare the transduction efficiency of the two vectors in vivo.
To assess and compare the efficacy of cell transduction in vitro, three distinct cell types were tested: 293T cells, rat-derived primary CNS cortical cultures and panpurified A2B5+ oligodendrocyte progenitor cells (Figure 1a ). Cells were cultured with virus for 24 h and the percentage of enhanced green flourescent protein (EGFP)+ cells was calculated 72 h later. FV readily transduced dividing cells and primary cell cultures in vitro with a similar efficiency to LV (Figure 1b) . However, FV failed to transduce A2B5+ progenitor cells in vitro, in contrast to LV, which readily transduced these cells, although with lesser efficiency when compared with primary cultures and cell lines. These differences are likely related to the rate at which different cultures actively divide and the apparent inability of FV to incorporate into cells in G 0 or diminished efficiency in cells that divide slowly.
To assess and compare the efficacy of cell transduction in vivo, FV and LV were injected into the corpus callosum of adult rats in accordance with the NIH Animal Protection Guidelines, which were approved by Institu- pcmv-cytomegalovirus promoter ; EGFP-enhanced green fluorescent protein Figure 1 Lentivirus (LV) transduces primary purified cell cultures more efficiently than foamy virus (FV). Replication incompetent FV and LV were produced according to published protocols used to generate high titer LV. 15 Viral titers were determined on 293T cells, and FV was subsequently diluted 10-fold in all experiments to allow for equivalent titers to be compared. Four plasmids, 1 (kind gift of Dr Russell) one of which was modified to include an MND promoter sequence driving enhanced green flourescent protein (EGFP) expression (a), were used to transduce 293T cells in 20 75 cm 2 flasks. Virus was concentrated by centrifugation at 50 000 g and resuspended in 100 ml of serum-free DMEM. A 5 ml aliquot of virus was thawed and mixed with 1 ml of protamine sulfate (4 mg ml À1 ) and incubated for 20 min at room temperature (RT). Virus was then added to fresh culture media and applied to cells. After 48 h, medium was changed and the percentage of green cells/visual field was assessed using an inverted fluorescent microscope. Although FV efficiently transduced both 293T cells and primary cortical-derived rat brain cultures, it failed to transduce A2B5+ cells in culture and overall was less efficient in primary cell cultures than LV. Gene transfer to the CNS with foamy virus AV Caprariello et al virus entry and gene expression in the absence of permanent integration into all cells. Although LVtransduced tissue volume was also reduced at 8 weeks, LV integrated into the genome more effectively, maintaining 31.6% of the initially transduced volume compared with FV, which only maintained 2.5%. These data bring to light an important caveat regarding long-term gene delivery using FV: despite the presence of stable pre-integration complexes within transduced cell nuclei, long-term gene expression is feasible only in tissues that are actively dividing.
To investigate the relationship between FV-mediated transduction and the cell cycle, bromodeoxyuridine (BrdU) was injected (100 mg kg À1 ) intraperitoneally daily for 5 days after injection of virus into the brain parenchyma. Rats were again killed at 1 and 8 weeks, the EGFP+ volume was calculated and immunohistochemical analysis was performed using anti-BrdU antibody (Roche Inc, Pleasanton, CA, USA). At 1 week, EGFP+ signal was identified in both BrdU+ and BrdUÀ cells in the brain after both FV and LV injections ( Figure  3, top 2 panels) . However, at 8 weeks post-injection of FV, the overlap of BrdU+ cells with EGFP+ cells was distinctly different (Figure 3, bottom 2 panels) . Namely, the EGFP+ signal was confined to BrdU+ cells, suggesting a cell-cycle dependence of FV for long-term gene expression. A restriction to proliferating cells is consistent with the extensive loss of FV-infected volume at 8 weeks and supports a transient phase of transduction and transgene expression that is highly efficient but temporally limited. In contrast, at 8 weeks, LV facilitated long-term transgene expression in cells that were both BrdU+ and BrdUÀ. This supports the well-documented ability of LV to maintain expression in post-mitotic cells for a sustained period of time. 17, 18 Multiple reports have shown the ability of FV to efficiently transduce CNS-derived cells in vitro, 13, 19 but to our knowledge this is the first report showing in vivo applications of FV to the CNS. To fully exploit the advantageous characteristics of FV, however, it is necessary to first define the pattern of transduction, gene expression and integration of FV into the CNS, as we have explained in this brief communication. Herein we have shown that high-titer FV efficiently transduces brain parenchyma at 1 week post-injection. This transduction and gene expression are cell cycle-independent, as indicated by discordant BrdU+ signal and EGFP signal. A high level of FV transduction suggests that it might be a very useful mechanism to facilitate widespread gene expression over a short time period. At 8 weeks, the differences in transduced brain volume between FV and LV are not statistically significant. This indicates that despite its initial gains, over time, integration and transgene expression by FV are at best equal to Figure 2 Compared with lentivirus, foamy virus is able to transiently transduce large volumes of brain parenchyma, however, with less efficient integration and subsequent long-term transgene expression. Access to brain parenchyma was accomplished by the placement of bilateral burr holes through the skull, 0.0 mm anterior and À2.0 mm and +2.0 lateral to bregma with injection occurring at a depth of 3.4 mm. A volume of 5 ml of virus was injected into the left corpus callosum at a rate of 0.25 ml min À1 followed by the removal of the needle at 1 mm min À1 . Immediately after removal, injection was carried out into the contralateral corpus callosum in an identical manner. Rats were killed at 1 and 8 weeks and perfused with approximately 150 ml of 0.9% saline over 20 min. Immediately after saline treatment, animals were perfused with approximately 150 ml of 4% PFA for 20 min. The entire brain was removed and post-fix immersed in 4% PFA overnight at 4 1C and then cryoprotected in sucrose for 24 h. Finally, the brain was embedded in OCT and sectioned. Every thin section with enhanced green flourescent protein (EGFP)+ cells was photographed, the gross anatomy outlined (including the EGFP+ region) and the infected tissue was reconstructed using the FDA-approved 3D-Doctor software (Able Software Corp., Lexington, MA, USA). In addition to being able to visualize the transduced (EGFP+) region in three dimensions, the software also provided quantitative transduction volumes. The calculated brain volume transduced by FV at 1 week post-injection was 20.5 mm 3 compared with LV which transduced 1.17 mm 3 . At 8 weeks post-injection, only 0.521 mm 3 was transduced by FV and 0.367 mm 3 by LV (n ¼ 4).
Gene transfer to the CNS with foamy virus AV Caprariello et al LV. Nevertheless, this characteristic holds considerable promise for selectively examining clonal relationships between neural cells and targeting transduction to particular cell populations through timing and localization of virus administration. Ultimately, we would propose using this knowledge to generate a lenti-foamy hybrid virus, which incorporates the highly efficient transient transduction ability and chromosomal integration pattern of FV with the ability of LV to efficiently and permanently integrate into post-mitotic tissue.
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